[1] KARIMI P,ISLAMI F,ANANDASABAPATHY S, et al. Gastric cancer:descriptive epidemiology, risk factors, screening, and prevention[J]. Cancer Epidemiol Biomarkers Prev,2014,23(5):700-713. [2] ALBEROBELLO A T, D'ESPOSITO V,MARASCO D,et al. Selective disruption of insulin-like growth factor-1(IGF-1) signaling via phosphoinositide-dependent kinase-1 prevents the protective effect of IGF-1 on human cancer cell death[J].J Biol Chem,2010,285(9):6563-6572. [3] SCARTOZZI M,MANDOLESI A,GIAMPIERI R,et al. Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan[J].Int J Cancer,2010,127(8):1941-1947. [4] SU C,WANG W,WANG C.IGF-1-induced MMP-11 expression promotes the proliferation and invasion of gastric cancer cells through the JAK1/STAT3 signaling pathway[J].Oncol Lett,2018,15(5):7000-7006. [5] GANGULY S,BASU B,SHOME S, et al. Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Kruppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation[J].Am J Pathol,2010,177(6):2701-2707. [6] ZHAO Q,TRAN H,DIMITROV D S, et al. A dual-specific anti-IGF-1/IGF-2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma[J].Int J Cancer, 2015, 137(9):2243-2252. [7] LICHTENSTEIN M J,MULROW C D,ELWOOD P C. Guidelines for reading case-control studies[J].J Chronic Dis,1987, 40(9):893-903. [8] 李冬斌, 韩锦胜, 王英霞,等. 胃癌中IGF-Ⅰ、Ⅱ及IGF-ⅠR的表达与临床病理关系的研究[J]. 河北医药, 2013,35(8):1125-1128. [9] 胡东昊. 胰岛素样生长因子-1及其结合蛋白-3在胃癌诊断中的应用[J]. 中国慢性病预防与控制, 2015, 23(3):211-213. [10] 张海峰, 申兴斌, 刘莎莎,等. IGF-1及IGF-1R在胃癌中的表达及意义[J]. 中国微生态学杂志, 2016, 28(12):1440-1442. [11] 徐航. Klotho和IGF-1在胃癌中的表达及意义[D].长沙:中南大学,2013. [12] 夏惠丽. IGF-1与bcl-2在胃癌组织中的表达及其相关性[D].郑州:郑州大学,2005. [13] 丁娟娟, 王邦茂, 方维丽,等. 胰岛素样生长因子-Ⅰ及其受体在胃癌的表达和意义[J]. 胃肠病学和肝病学杂志, 2009,18(2):103-105. [14] 宋晓华. IGF-Ⅰ、IGF-Ⅱ在胃癌中的表达及临床意义[J]. 河北医学, 2010,16(6):654-657. [15] 张雪英, 吉兆宁. 胃癌中IGFBP-2、IGFI、IGFIR的表达及意义[J]. 皖南医学院学报, 2008, 27(2):98-101. [16] 曹友红, 许春芳, 马平,等. 胰岛素样生长因子-1及其受体在胃癌中的表达及临床意义[J]. 世界华人消化杂志, 2014,22(22):3307-3315. [17] 吴跃文, 何杨, 吉兆宁,等. 胃癌中胰岛素样生长因子结合蛋白-2,胰岛素样生长因子-1和增殖细胞核抗原的表达和临床意义[J]. 中国临床医学, 2008,15(1):70-72. [18] 罗祖炎, 李博, 徐文娟,等. IGF-1在胃癌组织中的表达及其与浸润转移的关系[J]. 肿瘤学杂志, 2012, 18(4):254-258. [19] DANG X,LI X,WANG L, et al. MicroRNA-3941 targets IGF-1 to regulate cell proliferation and migration of breast cancer cells[J].Int J Clin Exp Pathol,2017,10(7):7650-7660. [20] HADDADI N,LIN Y,TRAVIS G, et al. PTEN/PTENP1:‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy[J]. Mol Cancer, 2018,17(1):37. [21] 张海峰, 赵杨, 刘莎莎,等. IGF-1、IGF-1R及VEGF在胃癌中的表达及其与浸润转移的关系[J]. 标记免疫分析与临床,2018,25(3):360-364. [22] 刘勇进, 俞列群, 叶帆. 非小细胞肺癌组织中HIF-1α、EGFR、IGF-1的表达及临床意义[J]. 医学研究杂志, 2018,47(5):78-82. [23] JU J,HAN C,ZAN L, et al. Expression of insulin-like growth factor 1 and its receptors in colorectal cancer and their significances[J]. Int J Clin Exp Pathol,2017,29(9):593-597. [24] 徐红, 郭明华, 吕旻彦,等. IGF-1及IGFBP-3在子宫内膜癌组织中的表达及意义[J]. 实用妇产科杂志, 2011, 27(12):901-904. [25] TANG J,JUN-JUN L I, ZHANG Y, et al. Expression and clinical significance of IGF-1 and IGF-1R in epithelial ovarian cancer patients[J]. China J Modern Med,2014,24(27):54-58. [26] WANG H,WANG C,TIAN W, et al. The crucial role of SRPK1 in IGF-1-induced EMT of human gastric cancer[J]. Oncotarget, 2017, 8(42):72157-72166. [27] XU L,ZHOU R,YUAN L, et al. IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis[J]. Cancer Lett, 2017, 393:76-85. [28] ZHANG H F,SHEN X B,LIU S S, et al. Effects of IGF-1 down-regulation on proliferation,migration and invasion of human gastric cancer cells[J].Chin J Cancer Prevent Treatment,2017,24(1):16-22. |